Who makes CNA3103: 1.5 x 10^9 cells?

CNA3103: 1.5 x 10^9 cells is developed by Carina Biotech Limited.

What development phase is CNA3103: 1.5 x 10^9 cells in?

CNA3103: 1.5 x 10^9 cells is in Phase 1.

Last reviewed 2026-04-19 · How we verify

CNA3103: 1.5 x 10^9 cells

Carina Biotech Limited · Phase 1 active Biologic

At a glance

Generic name	CNA3103: 1.5 x 10^9 cells
Sponsor	Carina Biotech Limited
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

CNA3103: 1.5 x 10^9 cells CI brief — competitive landscape report
CNA3103: 1.5 x 10^9 cells updates RSS · CI watch RSS
Carina Biotech Limited portfolio CI